Shelia M. Violette

CIK: 0002016144

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (28.6%)

Position reduction

Option Exercises (M)3 (21.4%)

Derivative conversions

Awards (A)3 (21.4%)

Compensation grants

Other (G, F, J, C, D, …)4 (28.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

QTTB

Q32 Bio Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (14 total)

QTTB
Q32 Bio Inc.
Oct 6, 2026
Sale(S)
Direct
917 shares at avg. $8.32$8K
QTTB
Q32 Bio Inc.
Aug 25, 2026
Sale(S)
Direct
2.8K shares at avg. $16.56$46K
QTTB
Q32 Bio Inc.
Jul 16, 2026
Award(A)
Direct
37.5K shares-
QTTB
Q32 Bio Inc.
Feb 25, 2026
Sale(S)
Direct
2.8K shares at avg. $4.51$13K
QTTB
Q32 Bio Inc.
Feb 24, 2026
Award(A)
Direct
37.5K shares-
QTTB
Q32 Bio Inc.
Aug 26, 2025
Sale(S)
Direct
3K shares at avg. $1.80$5K
QTTB
Q32 Bio Inc.
Feb 24, 2025
Disposition(D)
Stock Option (Right to Buy)
Direct
56.4K shares-
QTTB
Q32 Bio Inc.
Feb 24, 2025
Disposition(D)
Stock Option (Right to Buy)
Direct
32.9K shares-
QTTB
Q32 Bio Inc.
Feb 24, 2025
Disposition(D)
Stock Option (Right to Buy)
Direct
13.3K shares-
QTTB
Q32 Bio Inc.
Feb 24, 2025
Disposition(D)
Stock Option (Right to Buy)
Direct
17.5K shares-
QTTB
Q32 Bio Inc.
Feb 24, 2025
Award(A)
Direct
37.5K shares-
QTTB
Q32 Bio Inc.
Oct 15, 2024
Exercise(M)
Direct
6K shares at avg. $7.29$44K
QTTB
Q32 Bio Inc.
Oct 11, 2024
Exercise(M)
Direct
4.6K shares at avg. $3.12$14K
QTTB
Q32 Bio Inc.
Oct 8, 2024
Exercise(M)
Direct
13.3K shares at avg. $3.12$41K

		Type	Shares	Price		Ownership
Oct 6, 2026	QTTB Q32 Bio Inc.	Sale(S)	917	$8.32	$7,629	Direct
Aug 25, 2026	QTTB Q32 Bio Inc.	Sale(S)	2,798	$16.56	$46,335	Direct
Jul 16, 2026	QTTB Q32 Bio Inc.	Award(A)	37,500	-	$0	Direct
Feb 25, 2026	QTTB Q32 Bio Inc.	Sale(S)	2,815	$4.51	$12,708	Direct
Feb 24, 2026	QTTB Q32 Bio Inc.	Award(A)	37,500	-	$0	Direct
Aug 26, 2025	QTTB Q32 Bio Inc.	Sale(S)	2,990	$1.80	$5,385	Direct
Feb 24, 2025	QTTB Q32 Bio Inc.	Disposition(D) Stock Option (Right to Buy)	56,413	-	-	Direct
Feb 24, 2025	QTTB Q32 Bio Inc.	Disposition(D) Stock Option (Right to Buy)	32,891	-	-	Direct
Feb 24, 2025	QTTB Q32 Bio Inc.	Disposition(D) Stock Option (Right to Buy)	13,305	-	-	Direct
Feb 24, 2025	QTTB Q32 Bio Inc.	Disposition(D) Stock Option (Right to Buy)	17,506	-	-	Direct
Feb 24, 2025	QTTB Q32 Bio Inc.	Award(A)	37,500	-	-	Direct
Oct 15, 2024	QTTB Q32 Bio Inc.	Exercise(M)	6,000	$7.29	$43,740	Direct
Oct 11, 2024	QTTB Q32 Bio Inc.	Exercise(M)	4,574	$3.12	$14,271	Direct
Oct 8, 2024	QTTB Q32 Bio Inc.	Exercise(M)	13,300	$3.12	$41,496	Direct

1-14 of 14 transactions

About Violette Shelia M.

Violette Shelia M. (SEC CIK 0002016144) files insider reports with the SEC as Chief Scientific Officer of Q32 Bio Inc. (QTTB).

Signal8 holds 9 ownership filings by Violette Shelia M., all Form 4s, filed between Oct 10, 2024 and Oct 14, 2026. Those filings report 14 transactions, from Oct 8, 2024 to Oct 6, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Violette Shelia M.'s filings is in WALTHAM, MA.

Recent filings by Violette Shelia M.

Oct 6, 2026: Open-market sale of QTTB shares (Form 4, code S).
Aug 25, 2026: Open-market sale of QTTB shares (Form 4, code S).
Jul 16, 2026: Grant or award of QTTB shares (Form 4, code A).
Feb 25, 2026: Open-market sale of QTTB shares (Form 4, code S).
Feb 24, 2026: Grant or award of QTTB shares (Form 4, code A).

Other insiders filing for Q32 Bio Inc. (QTTB)

Morrison Jodie Pope, CEO
Kalowski Lee, CFO and President
TZIANABOS ARTHUR, Director
Lundberg Sven Ante, Director
LAPORTE KATHLEEN, Director
Iwicki Mark T, Director

How to read Form 4 transaction codes